Literature DB >> 30406600

Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal.

Mahnaz Davoudi1, Hossein Azizi2, Javad Mirnajafi-Zadeh3, Saeed Semnanian4.   

Abstract

Acute opioid withdrawal syndrome is a series of neurological symptoms caused by the abrupt cessation of the chronic administration of opioids such as morphine. The locus coeruleus (LC) in the brain stem receives a dense projection of orexinergic fibers from the hypothalamus and is a candidate site for the expression of the somatic aspects of morphine withdrawal. Previous studies have shown that orexin-A contributes to the behavioral symptoms of naloxone-induced morphine withdrawal, partly by reducing the activity of GABAergic neurons, suggesting that orexin-A may negatively modulate fast GABAergic neurotransmission during morphine withdrawal. We used whole-cell patch-clamp recordings of LC neurons in brainstem slices to investigate the effect of orexin-A on bicuculline-sensitive GABAergic inhibitory postsynaptic currents (IPSCs) during naloxone-induced morphine withdrawal. Male Wistar rats (P14-P21) were given morphine (20 mg/kg, i.p.) daily for seven consecutive days to create dependency on the drug. The application of naloxone (1 µM) to brain slices of morphine-treated rats reduced the amplitude of evoked IPSCs (eIPSCs) as well as spontaneous IPSCs (sIPSCs) frequency but did not change sIPSCs amplitude. Orexin-A (100 nM) significantly enhanced the suppressive effect of naloxone on eIPSCs amplitude and sIPSCs frequency but had no effect on the presence of the orexin type 1 receptor (OX1R) antagonist, SB-334867. Orexin-A alone had no significant effect on eIPSCs and sIPSCs in the absence of naloxone. In summary, our results show that orexin-A, via OX1R, potentiates the suppressive effect of naloxone on GABAergic IPSCs of LC neurons in morphine-treated rats. We conclude that orexins may have a critical role in regulating GABAergic neurotransmission to LC neurons during naloxone-induced morphine withdrawal.

Entities:  

Keywords:  GABAA-IPSCs; Locus coeruleus; Naloxone-induced morphine withdrawal; Orexin; Orexin type 1 receptor

Mesh:

Substances:

Year:  2018        PMID: 30406600     DOI: 10.1007/s12576-018-0645-1

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  52 in total

1.  Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling.

Authors:  S Chakrabarti; M Oppermann; A R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Role of different brain structures in the expression of the physical morphine withdrawal syndrome.

Authors:  R Maldonado; L Stinus; L H Gold; G F Koob
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

3.  Peripheral nerve injury potentiates excitatory synaptic transmission in locus coeruleus neurons.

Authors:  Kambiz Rohampour; Hossein Azizi; Yaghoub Fathollahi; Saeed Semnanian
Journal:  Brain Res Bull       Date:  2017-01-16       Impact factor: 4.077

4.  Electrical coupling synchronizes subthreshold activity in locus coeruleus neurons in vitro from neonatal rats.

Authors:  M J Christie; J T Williams; R A North
Journal:  J Neurosci       Date:  1989-10       Impact factor: 6.167

5.  The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.

Authors:  Mahnaz Davoudi; Hossein Azizi; Javad Mirnajafi-Zadeh; Saeed Semnanian
Journal:  Neurosci Lett       Date:  2016-02-12       Impact factor: 3.046

6.  Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat.

Authors:  B Florán; C Barajas; L Florán; D Erlij; J Aceves
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats.

Authors:  Bita Hooshmand; Hossein Azizi; Mohammad Javan; Saeed Semnanian
Journal:  Neurosci Lett       Date:  2016-11-02       Impact factor: 3.046

8.  micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.

Authors:  Anuradha Madhavan; Li He; Garret D Stuber; Antonello Bonci; Jennifer L Whistler
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

9.  Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.

Authors:  Yu-Cheng Ho; Hsin-Jung Lee; Li-Wei Tung; Yan-Yu Liao; Szu-Ying Fu; Shu-Fang Teng; Hsin-Tzu Liao; Ken Mackie; Lih-Chu Chiou
Journal:  J Neurosci       Date:  2011-10-12       Impact factor: 6.167

10.  Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.

Authors:  Hossein Azizi; Javad Mirnajafi-Zadeh; Kambiz Rohampour; Saeed Semnanian
Journal:  Neurosci Lett       Date:  2010-08-02       Impact factor: 3.046

View more
  3 in total

1.  PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal.

Authors:  Mahnaz Davoudi; Kamini Vijeepallam; Hossein Azizi; Javad Mirnajafi-Zadeh; Saeed Semnanian
Journal:  J Neural Transm (Vienna)       Date:  2019-09-06       Impact factor: 3.575

Review 2.  Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.

Authors:  Reda M Chalhoub; Peter W Kalivas
Journal:  Drugs       Date:  2020-10       Impact factor: 9.546

Review 3.  Physiological Role of Orexinergic System for Health.

Authors:  Ines Villano; Marco La Marra; Girolamo Di Maio; Vincenzo Monda; Sergio Chieffi; Ezia Guatteo; Giovanni Messina; Fiorenzo Moscatelli; Marcellino Monda; Antonietta Messina
Journal:  Int J Environ Res Public Health       Date:  2022-07-08       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.